Navigation Links
Implantable Device May Ease Tough-to-Treat Hypertension
Date:7/27/2011

e researchers looked at several factors over the course of the study. These included a reduction in systolic blood pressure at six and 12 months, the safety of the operation needed to implant the device, the safety of baroreflex activation therapy and the safety of the device itself.

At monthly visits, if a patient's target was not met, the voltage was upped to further lower blood pressure.

The device did work well in many patients, the researchers reported. During the first six months, 42 percent of those whose device was turned on got their systolic blood pressure down to 140 mmHg, compared with 24 percent of those whose device was not yet switched on.

In addition, there was a 40 percent reduction in the rate of problems caused by high blood pressure in the group whose device was turned on.

At one year, with the device now active in both groups, 52 percent of the patients reached the blood pressure goal of 140 mmHg, Bisognano said. He added that while using the device patients continued to take their blood pressure medications as usual.

However, there was no further reduction in systolic blood pressure among patients who received baroreflex activation therapy for a year, compared with those who received it for six months, Bisognano's group noted.

There were some safety issues as well. Some patients had problems stemming from the placement of the electrodes in the neck, including permanent nerve damage and complications from the surgery itself. And although most patients (74.8 percent) had no problems, that rate was still below the 82 percent the researchers had been hoping for, Bisognano said.

Approval of the device by the U.S. Food and Drug Administration is still years away, if ever. While a price tag for the device plus implantation is yet uncertain, Bisognano said he believes the treatment will be cost-effective given the cost of taking care of patients who suffer heart attacks or strokes from hypertension. And he n
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Implantable Device May Help Ease Tough Migraines
2. Implantable Device May Lower Tough-to-Treat Hypertension
3. Many May Get Unneeded Implantable Defibrillators
4. Implantable Sensor Measures Blood Sugar Levels
5. Vital functions monitored with wearable and implantable devices
6. UT Southwestern ophthalmologist helps develop device for monitoring degenerative eye disease
7. Internal bleeding higher with popular heart device than earlier model
8. Children experience wrist and finger pain when using gaming devices and mobile phones over time
9. New Stanford device could reduce surgical scarring
10. ESC Policy Conference makes recommendations for new EU medical device legislation
11. Researchers develop device to measure brain temperature non-invasively
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Implantable Device May Ease Tough-to-Treat Hypertension 
(Date:6/18/2013)... Palo Alto has taken yet another step ... with its recent major long-term solar power commitment. , ... electric power purchase agreements , which together will result in ... photovoltaic electric power per year, which is the equivalent of ... enough power to supply all 65,000+ Palo Alto residents---and then ...
(Date:6/18/2013)... Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at ... on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. ... Verano and will go to the lucky golfer at the ... , The MFHS golf tournament is open to all interested ... crew team for 18 holes. The fee is $125 per ...
(Date:6/18/2013)... 2013 Internationally acclaimed plastic surgeon, ... thebestbreast.com, showcasing his unique approach to breast augmentation. ... his surgical method and highlights the results of ... website, Dr. Tebbetts compares his breast augmentation method ... Tebbetts’ method does not necessitate the use drains, ...
(Date:6/18/2013)... Hospitals Case Medical Center clinical researchers have launched ... which will evaluate the ability of a patient,s ... end stage peripheral arterial disease (PAD). , ... Surgery at University Hospitals Case Medical Center,s Harrington ... at Case Western Reserve University School of Medicine, ...
(Date:6/18/2013)... signaling network between two previously unconnected proteins, exposing a ... growth at its starting point. , A team led ... Cancer Center reported the tie between epidermal growth factor ... a protein vital to the first step in DNA ... . , "MCM7 overexpression marks cell proliferation and is ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2
... images offers the possibility of using magnetic resonance imaging ... path of many degenerative brain diseases, report scientists at ... of California, San Francisco. The technique, developed by ... Bruce Miller, MD, clinical director of the UCSF Memory ...
... , TUESDAY, April 10 (HealthDay News) -- Black people with ... cardiac death than whites or other racial groups who suffer ... was true regardless of blacks, other risk factors, such as ... Researchers examined 533 black and 8,660 non-black patients ...
... passed the motor vehicle administration,s vision test may not mean ... found that the frequency and distance at which drivers with ... night was severely reduced, even when the drivers have passed ... are very common and lots of people with these conditions ...
... in low- and middle-income countries, and there is an ... help tackle the disease, states an analysis in CMAJ ... more people than HIV/AIDS, tuberculosis and malaria combined. The ... rise through 2030 of 82% in low- and lower-income ...
... San Diego, CA - The American Society of Pediatric ... April 22, during the 2012 Combined Otolaryngology Spring Meetings ... in San Diego, CA. During the ASPO meeting, ... scientific sessions featuring expert panelists will be presented focusing ...
... Doheny HealthDay Reporter , MONDAY, April 9 ... protect against repeat heart attacks, strokes or other cardiovascular ... surprised at these findings because I assumed that there ... Dr. Seung-Kwon Myung, chief of the carcinogenesis branch of ...
Cached Medicine News:Health News:New MRI technique may predict progress of dementias 2Health News:High Blood Pressure May Be Especially Lethal for Blacks 2Health News:Can a standard vision test predict nighttime driving performance? 2Health News:Scientific session and new research highlights 2Health News:Omega-3 Supplements No Help Against Repeat Heart Trouble: Review 2Health News:Omega-3 Supplements No Help Against Repeat Heart Trouble: Review 3
(Date:6/18/2013)... N.J. , June 18, 2013  Actavis, Inc. (NYSE: ... Actavis") has filed with the U.S. Securities and Exchange Commission ... Actavis, proposed acquisition of Warner Chilcott plc (NASDAQ: ... of Actavis and Warner Chilcott (the "Form S-4"). ... and Warner Chilcott have entered into a definitive ...
(Date:6/18/2013)... June 18, 2013  Recent regulatory and budget challenges ... Education groups at large pharmaceutical companies to effectively educate ... effective use of their new products. With the pressure ... is crucial that these "Med Ed" groups ... To address the changes that are transforming the ...
(Date:6/18/2013)... LEANDRO, Calif. , June 18, 2013  Cataracts ...  According to the American Association of Ophthalmology, aging is ... a clouding of the eye,s natural lens. 22 million ... 2020, as Baby Boomers continue to age, that number ... high tech world of iPhones, iPads, smart-phones and computers, ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3
... LLC ("Deston") announced today that it is currently exploring its ... Otic Solution ("Auralgan") by the Federal Government and that it ... product. "Despite the recent actions by the ... effective treatment for ear pain and inflammation," said David Preston ...
... N.J., Feb. 25, 2011 ConvaTec, a world-leading developer ... hospital care, today announced a new appointment to its ... Senior Vice President and Chief Quality Officer for ConvaTec ... member of the ConvaTec Executive Committee. McNally will be ...
Cached Medicine Technology:Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 2Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 3Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: